ArticleBone marrow transplantation2025
Divergent prognostic factors in high-risk vs. standard-risk patients aged 50-65 years after allo-HCT for AML/MDS: a single-center retrospective analysis.
Wenwen Guo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.